Imricor gets distribution boost in Europe with new Philips deal

Imricor has enlisted the help of Philips' global sales team to help drive lab adoption of its iCMR technology. (Pic: Getty)
Medical Tech company Imricor (ASX:IMR) continued its rally from March lows with a new distribution agreement this morning.
Amid a flurry of 4C filings for the June quarter, Imricor’s announcement made it one of the few small caps this morning with a trading update that moved the needle.
The company announced a deal with multinational electronics company Philips, which will see the Dutch conglomerate sell Imricor’s product as part of a sales portfolio for products that have achieved Europe’s CE Mark regulatory approval.
IMR shares rose by another 21 per cent in morning trade, as the stock hit a new 2020 high of $2.12 after falling to around 80c at the height of the COVID-19 crisis.
Imricor (ASX:IMR) share price chart
Sales boost
The distribution deal is for Imricor’s Advantage-MR EP Recorder/Stimulator System, which allows a physician to use both an EP recording system and a cardiac stimulator during an interventional magnetic resonance imaging (MRI) procedure.
The non-exclusive agreement “enables Philips to utilise their extensive sales force to drive iCMR lab adoption, providing a single point of purchase for these customer sites”.
Imricor CEO Steve Wedan said having the backing of a multinational to help drive lab adoption of the interventional cardiovascular magnetic resonance (iCMR) procedure is a “major milestone” for the company.
Having a distribution partner will also help the company focus on its core strengths — “supporting utilisation, growing our portfolio of consumable devices and expanding our indications for use”, Wedan said.
The deal with Philips was struck on three-year terms, with automatic 12-month rollovers thereafter unless cancelled by either party.
UNLOCK INSIGHTS
Discover the untold stories of emerging ASX stocks.
Daily news and expert analysis, it's free to subscribe.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.